ArticleIn vivo (Athens, Greece)

Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed Ovarian Cancer.

Aeran Seol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.